Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:18:46.912Z.
Calculation as of: 2026-10-06T21:18:46.912Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f896dd83f1f74da7f4e84885d6bb04cd833df246353afdbeec9bf8c0bdc7d1c4
EARNINGS YIELD
N/A
EARNINGS YIELD AVG TTM
55.02%
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
X4 Pharmaceuticals, Inc.
Market Cap
$261.27M
Earnings Yield
N/A
TTM Avg
55.02%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.43M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.92M
Earnings Yield
N/A
TTM Avg
0.57%
3Y Avg
0.57%
5Y Avg
0.57%
Market Cap
$259.56M
Earnings Yield
N/A
TTM Avg
7.35%
3Y Avg
8.08%
5Y Avg
6.30%
Market Cap
$259.49M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.14M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.12M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.63M
Earnings Yield
N/A
TTM Avg
24.17%
3Y Avg
24.17%
5Y Avg
24.17%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. (XFOR) | $261.27M | N/A | 55.02% | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | 0.57% | 0.57% | 0.57% |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A | 7.35% | 8.08% | 6.30% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $259.49M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | N/A | 24.17% | 24.17% | 24.17% |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | N/A | 6.60% | 6.60% | 6.49% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2025-08-08 | 142.95% |
| 2025-08-07 | 145.89% |
| 2025-08-06 | 134.81% |
| 2025-08-05 | 132.30% |
| 2025-08-04 | 134.81% |
| 2025-08-01 | 133.12% |
| 2025-07-31 | 126.79% |
| 2025-07-30 | 120.34% |
| 2025-07-29 | 110.36% |
| 2025-07-28 | 100.00% |
| 2025-07-25 | 117.03% |
| 2025-07-24 | 116.39% |
| 2025-07-23 | 142.00% |
| 2025-07-22 | 142.95% |
| 2025-07-21 | 139.22% |
| 2025-07-18 | 148.95% |
| 2025-07-17 | 142.95% |
| 2025-07-16 | 140.13% |
| 2025-07-15 | 144.90% |
| 2025-07-14 | 143.92% |
| 2025-07-11 | 148.95% |
| 2025-07-10 | 135.67% |
| 2025-07-09 | 128.31% |
| 2025-07-08 | 127.54% |
| 2025-07-07 | 126.04% |
| 2025-07-03 | 112.70% |
| 2025-07-02 | 107.58% |
| 2025-07-01 | 114.52% |
| 2025-06-30 | 112.11% |
| 2025-06-27 | 116.39% |
| 2025-06-26 | 106.50% |
| 2025-06-25 | 100.95% |
| 2025-06-24 | 92.61% |
| 2025-06-23 | 88.02% |
| 2025-06-20 | 79.78% |
| 2025-06-18 | 75.53% |
| 2025-06-17 | 77.74% |
| 2025-06-16 | 78.02% |
| 2025-06-13 | 75.53% |
| 2025-06-12 | 69.84% |
| 2025-06-11 | 66.36% |
| 2025-06-10 | 59.83% |
| 2025-06-09 | 51.45% |
| 2025-06-06 | 49.53% |
| 2025-06-05 | 57.57% |
| 2025-06-04 | 52.72% |
| 2025-06-03 | 53.79% |
| 2025-06-02 | 55.91% |
| 2025-05-30 | 62.65% |
| 2025-05-29 | 60.51% |
| 2025-05-28 | 65.54% |
| 2025-05-27 | 62.83% |
| 2025-05-23 | 68.71% |
| 2025-05-22 | 65.94% |
| 2025-05-21 | 76.90% |
| 2025-05-20 | 78.60% |
| 2025-05-19 | 72.95% |
| 2025-05-16 | 72.95% |
| 2025-05-15 | 70.53% |
| 2025-05-14 | 65.74% |
| 2025-05-13 | 64.35% |
| 2025-05-12 | 63.77% |
| 2025-05-09 | 63.20% |
| 2025-05-08 | 64.74% |
| 2025-05-07 | 65.74% |
| 2025-05-06 | 66.15% |
| 2025-05-05 | 64.55% |
| 2025-05-02 | 57.10% |
| 2024-11-13 | 30.77% |
| 2024-11-12 | 14.41% |
| 2024-11-11 | 12.86% |
| 2024-11-08 | 13.82% |
| 2024-11-07 | 13.84% |
| 2024-11-06 | 14.74% |
| 2024-11-05 | 15.34% |
| 2024-11-04 | 16.05% |
| 2024-11-01 | 16.44% |
| 2024-10-31 | 17.06% |
| 2024-10-30 | 16.44% |
| 2024-10-29 | 17.15% |
| 2024-10-28 | 17.07% |
| 2024-10-25 | 17.56% |
| 2024-10-24 | 17.61% |
| 2024-10-23 | 16.92% |
| 2024-10-22 | 16.89% |
| 2024-10-21 | 17.20% |
| 2024-10-18 | 16.42% |
| 2024-10-17 | 17.18% |
| 2024-10-16 | 16.01% |
| 2024-10-15 | 15.33% |
| 2024-10-14 | 15.29% |
| 2024-10-11 | 16.68% |
| 2024-10-10 | 16.28% |
| 2024-10-09 | 16.07% |
| 2024-10-08 | 15.77% |
| 2024-10-07 | 16.14% |
| 2024-10-04 | 13.73% |
| 2024-10-03 | 13.55% |
| 2024-10-02 | 14.00% |
| 2024-10-01 | 13.43% |
| 2024-09-30 | 12.75% |
| 2024-09-27 | 13.03% |
| 2024-09-26 | 12.93% |
| 2024-09-25 | 13.26% |
| 2024-09-24 | 11.92% |
| 2024-09-23 | 12.09% |
| 2024-09-20 | 12.07% |
| 2024-09-19 | 12.06% |
| 2024-09-18 | 12.13% |
| 2024-09-17 | 12.14% |
| 2024-09-16 | 12.88% |
| 2024-09-13 | 12.02% |
| 2024-09-12 | 12.59% |
| 2024-09-11 | 12.41% |
| 2024-09-10 | 12.37% |
| 2024-09-09 | 12.83% |
| 2024-09-06 | 13.10% |
| 2024-09-05 | 12.64% |
| 2024-09-04 | 12.48% |
| 2024-09-03 | 12.94% |
| 2024-08-30 | 12.19% |
| 2024-08-29 | 12.32% |
| 2024-08-28 | 12.37% |
| 2024-08-27 | 12.19% |
| 2024-08-26 | 11.69% |
| 2024-08-23 | 11.38% |
| 2024-08-22 | 11.22% |
| 2024-08-21 | 11.02% |
| 2024-08-20 | 11.56% |
| 2024-08-19 | 12.05% |
| 2024-08-16 | 12.28% |
| 2024-08-15 | 13.49% |
| 2024-08-14 | 13.91% |
| 2024-08-13 | 14.10% |
| 2024-08-12 | 13.42% |
| 2024-08-09 | 13.54% |
